Beauty Health discloses SEC subpoena; finalizes CEO Marla Beck employment terms

SkinHealth Systems Inc.

SEC's Enforcement Division issued subpoena in formal investigation; company cooperating, cannot predict scope or outcome.
Marla Beck named President and CEO effective April 8; receives $1M base salary, $500k special bonus, $6M equity award.
Annual bonus targeted at 100% of base; equity includes RSUs and PSUs with performance vesting tied to stock price milestones.
Executive severance plan amended: removes tiers for non-exec officers hired after March 2024, adds tenure-based cash severance.

item 5.02 item 8.01 item 9.01

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Role change

Marla Beck

President and Chief Executive Officer

SKIN · SkinHealth Systems Inc.

Effective: 2024-04-08
Filed: April 8, 2024, 7:59 PM ET

the Company’s Board of Directors (the “Board”) had unanimously approved Marla Beck to be the Company’s President and Chief Executive Officer.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Marla Beck was appointed as President and Chief Executive Officer at SkinHealth Systems Inc..

Action: appointed
Role: President and Chief Executive Officer

Exact text from the filing

the Company’s Board of Directors (the “Board”) had unanimously approved Marla Beck to be the Company’s President and Chief Executive Officer.

View on SEC.gov

SkinHealth Systems Inc. filing history →

Source: SEC EDGAR

accession 0001628280-24-015295

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.